Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Diagnostic Device for Tuberculosis

By HospiMedica staff writers
Posted on 30 Apr 2001
A new device being developed to diagnose tuberculosis (TB) has the potential to positively identify the disease and evaluate drug resistance of TB organisms within 48 hours. More...
Current diagnostic methods of evaluating infection and drug resistance often require three to six weeks, producing increasingly drug-resistant bacteria and reducing the likelihood of a cure.

The device incorporates a virus that emits light in the presence of live Mycobacterium tuberculosis. The light can be detected with a piece of film or a digital camera, providing doctors with a rapid and inexpensive method for identifying TB and determining TB drug susceptibility. The device is being developed by Sequella, Inc. (Rockville, MD, USA). The company has received a grant from the National Institute of Allergy and Infectious Disease (NIAID) that will aid the development of the device

The concept was originally developed by Dr. William Jacobs at the Albert Einstein College of Medicine (New York, NY, USA), who has licensed the technology to Sequella. "This technology is wonderfully innovative and promising, and we are pleased with the confidence that NIAID has in our ability to commercialize this product,” said Dr. Carol Nacy, CEO of Sequella.




Related Links:
Sequella

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.